(Q35677669)

English

Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study

scientific article published on 14 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

ChEBI release 2020-05-28

author name string

S-H Chien

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C-J Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Y-C Hong

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C-J Teng

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Y-W Hu

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C-C Shen

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

F-C Ku

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

S-C Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C-M Yeh

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

T-J Chiou

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J-P Gau

11

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C-H Tzeng

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

14 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

177-184

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

describes a project that uses

1 reference

Europe PubMed Central

26 June 2022

https://europepmc.org/article/PMC/PMC4453596

based on heuristic

inferred from PubMed Central ID database lookup

https://scigraph.springernature.com/pub.10.1038/bjc.2014.523

0 references

Epidemiology of esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Epidemiology of esophageal cancer in Japan and China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Secondary cancers following allogeneic haematopoietic cell transplantation in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Solid cancers after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Global epidemiology of oral and oropharyngeal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Azathioprine and UVA light generate mutagenic oxidative DNA damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

12 July 2018

New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.523

21 January 2018

Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.523

21 January 2018

Current status of hematopoietic stem cell transplantation in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.523

21 January 2018

Public health surveillance with electronic medical records: at risk of surveillance bias and overdiagnosis

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.523

21 January 2018

Solid cancers after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.523

21 January 2018

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.523

21 January 2018

A piece of my mind. Virtual grief.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.523

21 January 2018

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

25 September 2018

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453596

25 September 2018

The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary solid tumors after allogeneic hematopoietic SCT in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic stem cell transplantation for severe aplastic anemia--experience of an institute in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/25314066

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2014.523

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35677669&oldid=1667457448"